Results 161 to 170 of about 265,806 (236)

Improvement in Patient‐Reported Outcomes, High Rate of Return to Sport, and Secondary Surgery Rate Ranging From 0% to 9.8% After Hip Arthroscopy in Dancers and Athletes in Flexibility Sports: A Systematic Review

Arthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To systematically review and report patient‐reported outcome measures (PROMs), rates of return to sport, and secondary surgeries in dancers and flexibility sport athletes who underwent hip arthroscopy. Methods Using the 2020 Preferred Reporting Items for Systematic Reviews and Meta‐Analyses criteria, a systematic review was performed with a ...
David R. Maldonado, Andrew R. Schab, Benjamin G. Domb   +2 more
wiley   +1 more source

Reply: Including Vonoprazan With PPIs Challenges the Drug-Interaction Hypothesis. [PDF]

JACC Asia
Nishikura T, Yamamoto K, Watanabe H, Morimoto T, Kimura T.   +4 more
europepmc   +1 more source

Dual Labral and Ligamentum Teres Reconstruction Achieves High Functional Outcomes and Arthroplasty‐Free Survivorship at 2 Years

Arthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To evaluate the clinical outcomes and survivorship of hip arthroscopy with simultaneous labral and ligamentum teres (LT) reconstruction for the treatment of irreparable labral and LT tears, with a minimum follow‐up of 2 years. Methods Prospectively collected data were retrospectively reviewed for patients who underwent combined arthroscopic ...
Roger Quesada‐Jimenez, Krishi Rana, Matthew J. Strok, Ady H. Kahana‐Rojkind, Alexander K. Burt, Etan P. Sugarman, Benjamin G. Domb   +6 more
wiley   +1 more source

Determinants of Difficult‐to‐Manage and Treatment‐Refractory Axial Spondyloarthritis: A Cross‐Sectional Analysis Within a Longitudinal Cohort

Arthritis &Rheumatology, EarlyView.
Objective The purpose of this study was to estimate the prevalence of difficult‐to‐manage (D2M) and treatment‐refractory (TR) axial spondyloarthritis (axSpA) and to identify factors associated with D2M and TR disease in a longitudinal cohort. Methods We performed a cross‐sectional analysis on data from the Schroeder Arthritis Institute Spondylitis ...
Patricia Remalante‐Rayco, Laura Passalent, Tina Chim, Hannah Vijayan, Manal Alnasser, Zeynep Baskurt, Robert D. Inman, Nigil Haroon, Denis Poddubnyy   +8 more
wiley   +1 more source

Liver Aging Index: A Noninvasive Score for Liver Biological Aging and Liver-Related Outcomes in Multicohorts. [PDF]

Aging Cell
Wu Z, Wu S, Song S, Huang Y, Yu C, Sun D, Pei P, Yang L, Chen Y, Du H, Walters R, Millwood I, Xu H, Yang X, Chen J, Kim SU, Petta S, Nakajima A, Tsochatzis E, Boursier J, Bugianesi E, Chan WK, Romero-Gomez M, Calleja JL, de Lédinghen V, Castéra L, Sanyal AJ, Goh GB, Newsome PN, Fan JG, Lai M, Zhou XD, Chen Z, Lv J, Li L, Wong VW, Zheng MH, Pang Y, China Kadoorie Biobank Collaborative Group and VCTE‐Prognosis Study Group.   +38 more
europepmc   +1 more source

Non‐melanoma skin cancer risk with Janus kinase inhibitors compared to interleukin‐6 receptor inhibitors in rheumatoid arthritis: results from a national cohort study

Arthritis &Rheumatology, Accepted Article.
Background Non‐melanoma skin cancer (NMSC) is one of the most common malignancies in rheumatoid arthritis (RA). This analysis assessed NMSC risk with Janus kinase inhibitors (JAKi) compared to interleukin‐6 receptor inhibitors (IL‐6Ri). Method This study used data from the British Society for Rheumatology Rheumatoid Arthritis Register (BSRBR‐RA) linked
Zixing Tian, Lianne Kearsley‐Fleet, Sizheng Steven Zhao, James Galloway, Mark Lunt, Kath Watson, Narges Azadbakht, BSRBR‐RA Contributors Group, Kimme L Hyrich   +8 more
wiley   +1 more source

Seven-Year Valve Durability With Transcatheter or Surgical Aortic Valve Replacement: An Ad Hoc Analysis of the PARTNER 3 Randomized Clinical Trial.

JAMA Cardiol
Ternacle J, Hahn RT, Silva I, Alperi A, Giuliani C, Zanuttini A, Théron A, Dahou A, Cristell N, Woods T, Guzzetti E, Turgeon PY, Bernier M, Mahjoub H, Paquin A, Skaf S, Beaudoin J, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Leipsic J, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Généreux P, Pershad A, Nazif TM, Zhang Y, Gunnarsson M, Webb JG, Makkar RR, Thourani VH, Mack MJ, Leon MB, Pibarot P, PARTNER 3 Investigators.   +41 more
europepmc   +1 more source

Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+‐year results from a multicenter, open‐label study

Arthritis &Rheumatology, Accepted Article.
Objective To assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients 2–17 years with active pcJIA and inadequate response ...
Hermine I Brunner, Lyudmila Grebenkina, Irina Nikishina, Ekaterina Alexeeva, Vyacheslav Chasnyk, Carlos Abud‐Mendoza, Nadina Rubio‐Pérez, Heinrike Schmeling, María del Rocio Maldonado‐Velázquez, Diane Brown, Andrew Zeft, Esi Morgan, C. Egla Rabinovich, Daniel Kingsbury, Hulya Bukulmez, Beth Gottlieb, Thomas Griffin, Lisa Imundo, Stacey Tarvin, Earl Silverman, Laura Shaughnessy, Saori Shimizu, Paulette Williams, Rocío Lledó‐García, Gauri Utturkar, Baran Ufuktepe, Alberto Martini, Daniel Lovell, Nicolino Ruperto   +28 more
wiley   +1 more source

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial

Arthritis &Rheumatology, Accepted Article.
Objective To assess the efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with psoriatic arthritis (PsA) who were naive to biologic disease‐modifying antirheumatic drugs or received tumor necrosis factor inhibitors. Methods In the 52‐week (W), double‐blind, placebo‐controlled, phase 3 POETYK PsA‐2 study
Philip J. Mease, Vinod Chandran, April W. Armstrong, Ricardo Blanco, Alexis Ogdie, Evan L. Siegel, Alice B. Gottlieb, Xiaofeng Zeng, Diamant Thaçi, Mitsumasa Kishimoto, Hendrik Schulze‐Koops, Alan Kivitz, Eva Dokoupilová, Akimichi Morita, Eric M. Ruderman, Michael Plewinski, Kejia Wang, Caroline Sardinas, Eleni Vritzali, John Vaile, Atul Deodhar   +20 more
wiley   +1 more source

['الأحکام القانونیة للأتعاب الطبیة', 'Legal provisions for medical fees']

الرافدین للحقوق, 2009
Habeb Adres Isa Almazory
doaj